High performance liquid detection method of abiraterone acetate preparation
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 江苏万高药业股份有限公司
- Publication Date
- 2021-06-15
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a high-efficiency liquid phase detection method for abiraterone acetate preparations, in particular to a detection method for abiraterone acetate capsules, belonging to the field of drug quality control. Background technique
[0002] Abiraterone Acetate is a prodrug of Abiraterone, a selective irreversible inhibitor of 17α-hydroxylase / C17,20-lyase (CYP17). The enzyme is expressed in testis and adrenal gland tissues and catalyzes the conversion of pregnene and nandrolone and progesterone to testosterone precursors, DHEA and androstenedione, respectively, through 17α hydroxylation and cleavage of C17,20 bonds. Abiraterone can inhibit the activity of CYP17 to prevent testosterone synthesis in testes, adrenal glands and tumors. Due to the possible introduction of residual raw materials and other related substances in the production process of Abiraterone Acetate Soft Capsules, degradation products may also be produced during the s...